Enhabit Reports Fourth Quarter Results and Issues Full-Year 2023 Guidance

DALLAS, TX – Feb. 14, 2022 – Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice care provider, today reported its results of operations for the fourth quarter ended December 31, 2022.
“Significant changes were required in 2022 to lead important strategies for our future success,” said Enhabit’s President and Chief Executive Officer, Barb Jacobsmeyer. “The expansion of our human resource and talent acquisitions teams, the establishment of our payor innovation team, and strategic changes to management and our staffing model in hospice are all making notable progress. We have also taken steps to align our operational and sales teams into a regional structure to drive success clinically and operationally at a local level. While we face numerous headwinds in 2023, we remain confident in the long-term prospects for Enhabit.”


SUMMARY PERFORMANCE – CONSOLIDATED

• Net service revenue of $275.1 million, declined 0.4% from Q4’21


• Net income of $8.2 million, declined 72.5% from Q4’21


• Adjusted EBITDA of $40.3 million, down 17.8% from Q4’21


• Earnings per diluted share of $0.15


• Adjusted earnings per diluted share of $0.32

RECENT COMPANY HIGHLIGHTS

• Home health continues to have strong growth in Medicare Advantage with nine new negotiated agreements added during the fourth quarter.


• Strategic changes in hospice continue to provide positive momentum with average daily census growing sequentially during the fourth quarter.


• Nursing labor showing signs of improvement with a 19% year-over-year increase in our full-time nursing applicant pool.


• Completed three acquisitions and opened one home health de novo location in the fourth quarter, adding five hospice locations and two home health locations to our portfolio.

FINANCIAL RESULTS

Consolidated

The continued shift to more non-episodic patients in home health and the resumption of sequestration combined to decrease consolidated revenue approximately $11 million. The impact of these items were offset by an approximate $5 million audit recovery related to a prior year home health medical claims review, improved collections experience related to Medicaid in hospice, and an increase in hospice Medicare reimbursements rates effective October 1, 2022.


Adjusted EBITDA decreased primarily due to the revenue items discussed above, higher cost of services and incremental costs associated with being a stand-alone company. Cost of services were higher due to increased labor costs and costs associated with fleet and mileage reimbursement. Increased labor costs primarily resulted from a $4.3 million increase in employee group medical claims year over year.

SEGMENT RESULTS

Home health

Total admissions decreased primarily due to a reduction in episodic admissions partially offset by continued growth in non-episodic admissions. Revenue per episode decreased year over year primarily due to the resumption of sequestration and timing of completed episodes partially offset by an increase in Medicare reimbursement rates and an approximate $5 million audit recovery related to a prior year medical claims review.


Adjusted EBITDA decreased year over year primarily due to lower revenue and higher cost of services associated with labor and increased costs associated with fleet and mileage reimbursement. Increased labor costs primarily resulted from a $2.8 million increase in employee group medical claims.

Hospice

Revenue per day increased 5.8% year over year primarily due to an increase in Medicare reimbursement rates and improved collections experience related to Medicaid in hospice partially offset by the resumption of sequestration. Average daily census increased sequentially from the third quarter of 2022 primarily due to improvements in staffing capacity.


Adjusted EBITDA decreased year over year primarily due to increased labor costs and costs associated with fleet and mileage reimbursement. Increased labor costs primarily resulted from lower clinical productivity associated with nurses in orientation, increased use of contract labor, and a $0.5 million increase in employee group medical claims.

GUIDANCE


The Company is providing full-year 2023 guidance as follows:

For additional considerations regarding the Company’s 2023 guidance ranges, see the supplemental information provided in the quarterly earnings slide deck posted on the Company’s website at
http://investors.ehab.com. See also “Other Information” below for an explanation of why the Company does not provide guidance for comparable GAAP measures for Adjusted EBITDA and adjusted EPS.

CONFERENCE CALL INFORMATION


The Company will host an investor conference call at 10 AM Eastern Time on Feb. 15, 2023 to discuss its results for the fourth quarter of 2022. To access the live call by phone, dial toll-free (888) 660-6150 or international (929) 203-0843; the conference ID is 5248158. A simultaneous webcast of the call, along with supplemental information, may be accessed by visiting http://investors.ehab.com. Following the call, a replay will be available at the same location.


ABOUT ENHABIT HOME HEALTH & HOSPICE


Enhabit Home Health & Hospice is a leading national home health and hospice provider working to expand what’s possible for patient care in the home. Enhabit’s team of clinicians supports patients and their families where they are most comfortable, with a nationwide footprint spanning 252 home health locations and 105 hospice locations across 34 states. Enhabit leverages advanced technology and compassionate teams to deliver extraordinary patient care.

OTHER INFORMATION


Note regarding presentation of non-GAAP financial measures


The financial data contained in the press release and supplemental information includes non-GAAP financial measures as defined in Regulation G under the Securities Exchange Act of 1934, including Adjusted EBITDA, Adjusted EBITDA margin, leverage ratios, adjusted EPS, and adjusted free cash flow. Reconciliations of these non-GAAP financial measures to the most directly comparable financial measures calculated in accordance with GAAP are presented on the attached schedules.


However, in reliance on the exception provided by Item 10(e)(1)(i)(B) of Regulation S-K, reconciliation of its guidance of Adjusted EBITDA and adjusted EPS to their corresponding GAAP measures is not provided because the Company is unable to provide such reconciliation, without unreasonable effort, due to the inherent difficulty in predicting, with reasonable certainty, the future impact of items that are outside the control of the Company or otherwise non-indicative of its ongoing operating performance. Such items include, but are not limited to, gains or losses related to hedging instruments; loss on early extinguishment of debt; adjustments to its income tax provision (such as valuation allowance adjustments and settlements of income tax claims); and items related to corporate and facility restructurings. For the same reasons, the Company is unable to address the probable significance of the unavailable information.


Note regarding presentation of same-store comparisons


The Company uses “same-store” comparisons to explain the changes in certain performance metrics and line items within its financial statements. Same-store comparisons are calculated based on home health and hospice locations open throughout both the full current period and the immediately prior period presented. These comparisons include the financial results of market consolidation transactions in existing markets, as it is difficult to determine, with precision, the incremental impact of these transactions on the Company’s results of operations.

FORWARD-LOOKING STATEMENTS


Statements contained in this press release which are not historical facts, such as those relating to future events, projections, financial guidance, legislative or regulatory developments, strategy or growth opportunities, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All such estimates, projections, and forward-looking information speak only as of the date hereof, and Enhabit undertakes no duty to publicly update or revise such forward-looking information, whether as a result of new information, future events, or otherwise. Such forward-looking statements are necessarily estimates based upon current information and involve a number of risks and uncertainties. Actual events or results may differ materially from those anticipated in these forward-looking statements as a result of a variety of factors. While it is impossible to identify all such factors, factors which could cause actual events or results to differ materially from those estimated by Enhabit include, but are not limited to, our ability to execute on our strategic plans, regulatory and other developments impacting the markets for our services, changes in reimbursement rates, general economic conditions, our ability to attract and retain key management personnel and healthcare professionals, potential disruptions or breaches of our or our vendors’ information systems, the outcome of litigation, our ability to successfully complete and integrate de novo developments, acquisitions, investments, and joint ventures, and our ability to control costs, particularly labor and employee benefit costs. Our annual report on Form 10-K and subsequent quarterly reports on Form 10-Q, each of which will be available on the Company’s website at http://investors.ehab.com and the SEC’s website at www.sec.gov, discuss other risks and factors that could cause actual results to differ materially from those expressed or implied by any forward-looking statement in this press release. We urge you to consider all of the risks, uncertainties and factors identified above or discussed in such reports carefully in evaluating the forward-looking statements in this press release.


Investor Relations Contact


Mark Brewer
[email protected]
469-860-6061


Media Contact


Erin Volbeda
[email protected]
972-338-5141

Enhabit Home Health & Hospice Announces Date of 2022 Fourth Quarter Earnings Call

DALLAS – January 24, 2023 – Enhabit, Inc. (NYSE: EHAB), a leading national home health and hospice provider, today announced it will report its results for the fourth quarter ended
Dec. 31, 2022, on Feb. 14, 2023, and host a webcast and conference call on Feb. 15, 2023. Individuals who would like to participate in the conference call webcast should join 15 minutes before the scheduled start time.

  • Feb. 15, 2023
  • 10:00 a.m. Eastern
  • Toll-free: 888-660-6150
  • International: 929-203-0843
  • Conference ID: 5248158
  • Internet website: https://investors.ehab.com 

A link to the webcast of the conference call and online replay can be found on Enhabit’s investor website at the web address provided above.

###

About Enhabit Home Health & Hospice

Enhabit Home Health & Hospice (Enhabit, Inc.) is a leading national home health and hospice provider working to expand what’s possible for patient care in the home. Enhabit’s team of clinicians supports patients and their families where they are most comfortable, with a nationwide footprint spanning 252 home health locations and 105 hospice locations across 34 states. Enhabit leverages advanced technology and compassionate teams to deliver extraordinary patient care. For more information, visit ehab.com.  

Investor Contact

Mark Brewer [email protected] 469-621-6496

Media Contact

Erin Volbeda [email protected] 972-338-5141

Enhabit Announces Participation in Upcoming 23rd Annual “New Ideas for the New Year” Investor Conference

DALLAS – Dec. 27, 2022 – Enhabit, Inc. (NYSE: EHAB), a leading national home health and hospice provider, today announced its participation in the 23rd Annual “New Ideas for the New Year” Investor Conference.

Enhabit’s President and Chief Executive Officer Barbara Jacobsmeyer and Chief Financial Officer Crissy Carlisle will participate in a fireside chat on Wednesday, Jan. 11, 2023, at 11:00 a.m. ET. The fireside chat will be webcast live and available at https://investors.ehab.com.  

About Enhabit Home Health & Hospice  

Enhabit Home Health & Hospice (Enhabit, Inc.) is a leading national home health and hospice provider working to expand what’s possible for patient care in the home. Enhabit’s team of clinicians supports patients and their families where they are most comfortable, with a nationwide footprint spanning 250 home health locations and 100 hospice locations across 34 states. Enhabit leverages advanced technology and compassionate teams to deliver extraordinary patient care. For more information, visit ehab.com.

Investor relations contact

Crissy Carlisle [email protected] 214-239-6508

Media contact

Erin Volbeda [email protected] 972-338-5141

Enhabit Home Health & Hospice Appoints Dylan Black as General Counsel

DALLAS, Dec. 12, 2022 – Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice provider, today announced the appointment of Dylan Black as general counsel, effective January 2023.

“We are excited to welcome Dylan to the Enhabit team,” Enhabit President and CEO Barb Jacobsmeyer said. “He has served as a trusted legal advisor to many organizations, and we look forward to the leadership and contributions he will bring to Enhabit.”  

Black brings more than 24 years of legal experience helping publicly traded companies. Most recently, Black served as a partner at Bradley Arant Boult Cummings LLP where he represented companies across various industries including health care, banking and environmental services. In this role, he provided legal expertise to clients in the defense of securities and derivative lawsuits, class actions, professional liability claims and more. 

Black holds a Juris Doctor degree from the University of Virginia School of Law and a bachelor’s degree in government from Harvard University.

About Enhabit Home Health & Hospice

Enhabit Home Health & Hospice (Enhabit, Inc.) is a leading national home health and hospice provider working to expand what’s possible for patient care in the home. Enhabit’s team of clinicians supports patients and their families where they are most comfortable, with a nationwide footprint spanning 250 home health locations and 100 hospice locations across 34 states. Enhabit leverages advanced technology and compassionate teams to deliver extraordinary patient care. For more information, visit ehab.com.

Media contact 

Erin Volbeda [email protected] 972-338-5141 

Investor contact

Crissy Carlisle [email protected] 214-239-6508

Enhabit Home Health & Hospice Acquires Southwest Florida Home Care, Inc.’s Fort Myers, Fla. Location

DALLAS, Dec. 1, 2022 – Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice provider, today announced the acquisition of Southwest Florida Home Care, Inc.’s home health agency located in Fort Myers, Fla.

“We are excited to welcome the Southwest Florida Home Care employees to our Enhabit team,” Enhabit President and CEO Barb Jacobsmeyer says. “We look forward to continuing to support our new team members as we serve more patients in need of high-quality home health services.”

This acquisition increases Enhabit’s existing footprint in Florida, which now totals 22 home health locations. The Fort Myers location will expand Enhabit’s ability to serve the communities of southwest Florida.

Enhabit is the fourth largest provider of Medicare-certified home health services and the 12th largest provider of Medicare-certified hospice services nationally.

To learn more about Enhabit and its care offerings, visit ehab.com, and to apply to join the growing Enhabit team, visit careers.ehab.com

About Enhabit Home Health & Hospice

Enhabit Home Health & Hospice (Enhabit, Inc.) is a leading national home health and hospice provider working to expand what’s possible for patient care in the home. Enhabit’s team of clinicians supports patients and their families where they are most comfortable, with a nationwide footprint spanning 250 home health locations and 100 hospice locations across 34 states. Enhabit leverages advanced technology and compassionate teams to deliver extraordinary patient care. For more information, visit ehab.com.

Media contact 

Erin Volbeda [email protected]  972-338-5141 

Investor contact

Crissy Carlisle [email protected] 214-239-6508

Enhabit Home Health & Hospice Receives Two “Best Place to Work” Awards in Health Care

Enhabit receives Fortune’s “30 Best Large Workplaces in Health Care” and Modern Healthcare’s “Best Places to Work in Healthcare” awards

DALLAS–(BUSINESS WIRE)–Enhabit, Inc. (NYSE: EHAB), a leading national home health and hospice provider, announced today its recent placements in Fortune’s “30 Best Large Workplaces in Healthcare” awards as well as Modern Healthcare’s “Best Places to Work in Healthcare” awards series, highlighting Enhabit’s commitment to its people.

Enhabit placed #23 in Fortune’s “30 Best Large Workplaces in Health Care 2022,” making the list for the eighth year in a row. Placements are determined using an anonymous survey where employees can share confidential quantitative and qualitative feedback regarding the organization’s culture and structure exploring levels of trust, respect, credibility, fairness, and comradery. Modern Healthcare’s “Best Places to Work” awards series also conducts an assessment designed to gather detailed information about organizations in which employers complete an in-depth questionnaire and employees are given the opportunity to provide honest and anonymous feedback. For the tenth year in a row, Enhabit was included in Modern Healthcare’s winners, ranking #34 in the “Provider/Insurer” category this year.

“Our focus is on fostering an inclusive and welcoming workplace and culture, and to cultivate an authentic sense of belonging for all employees, which ultimately promotes better patient care and employee retention,” says Chief Human Resources Officer Tanya Marion. “We are thrilled to have received such prestigious awards as we continue to work to retain the highest quality employees to better serve our patients.”

Tanya Marion is Enhabit’s first chief human resources officer and has remained focused on employee engagement and retention. Amid a labor shortage within the health care sector, Marion’s extensive expertise in recruiting, leading and developing teams with a commitment to providing a better way to care have all contributed to Enhabit’s success with acquiring and retaining top talent.

“At Enhabit, we make it our mission to provide our employees with benefits that promote a culture that allows for work-life balance,” says Marion. “Our employees are our most important assets and we are committed to listening to their feedback as we continue to grow and diversify Enhabit’s workforce.”

Enhabit is one of the largest Medicare-certified home health and hospice providers in the nation, with over 10,000 employees across its vast footprint. Enhabit provides flexible schedules, professional development opportunities, a competitive compensation and benefits package and access to advanced technology to assist employees in providing industry-leading care to patients and their loved ones.

To learn more about Enhabit and its care offerings, visit ehab.com. To learn more about joining the Enhabit team, visit careers.ehab.com.

About Enhabit Home Health & Hospice

Enhabit Home Health & Hospice (Enhabit, Inc.) is a leading national home health and hospice provider working to expand what’s possible for patient care in the home. Enhabit’s team of clinicians supports patients and their families where they are most comfortable, with a nationwide footprint spanning 250 home health locations and 100 hospice locations across 34 states. Enhabit leverages advanced technology and compassionate teams to deliver extraordinary patient care. For more information, visit ehab.com.

Contacts

Erin Volbeda [email protected] 972-338-5141

Enhabit Reports Third Quarter Financial Results

DALLAS–(BUSINESS WIRE)– Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice care provider, today reported its results of operations for the third quarter ended September 30, 2022.

“We are making progress on our strategic initiatives,” Enhabit’s President and Chief Executive Officer, Barb Jacobsmeyer said. “During the quarter, labor constraints began to ease as our efforts around investment in our people began to take hold. We saw strong growth in Medicare Advantage admissions as we continued to expand in this growing part of our markets. The strategic and operational changes we are implementing in our hospice operations are having a positive impact as evidenced by our sequential growth in admissions and average daily census. We remain focused on the long-term growth of Enhabit.”

QUARTERLY PERFORMANCE – CONSOLIDATED

Consolidated third quarter 2022 results were impacted by the resumption of sequestration, continued shift to more non-episodic patients in home health, lower volumes in hospice, and higher cost of services related to labor, mileage reimbursement and fleet costs.

  • Net service revenue of $265.7 million, declined 3.0% from Q3’21
  • Net income of $8.6 million, declined 60.2% from Q3’21
  • Adjusted EBITDA of $31.7 million, down 26.3% from Q3’21
  • Earnings per diluted share of $0.17
  • Adjusted earnings per diluted share of $0.19

RECENT COMPANY HIGHLIGHTS

  • Home health continues to show strong growth in Medicare Advantage admissions, with non-episodic admissions up 31.5% year over year.
  • Strategic changes are providing positive momentum in hospice with sequential admissions and average daily census growth during the third quarter.
  • Agreed to terms with nine Medicare Advantage and commercial regional or multistate plans.
  • Completed the acquisitions of Caring Hearts Hospice and Unity Hospice on October 1, 2022 and November 1, 2022, respectively, adding four locations in Texas and one in Arizona.

FINANCIAL RESULTS

Consolidated

The resumption of sequestration, continued shift to more non-episodic patients in home health, and lower volumes in hospice combined to decrease consolidated revenue by $15 million year over year. 

Adjusted EBITDA decreased year over year primarily due to the resumption of sequestration; continued shift to more non-episodic patients in home health; lower volumes in hospice; higher costs of services related to labor; incremental costs associated with being a stand-alone company; and fleet and mileage reimbursement. 

SEGMENT RESULTS

Home health

The year-over-year decrease in revenue was due primarily to the resumption of sequestration and continued payor mix shift to more non-episodic patients. Revenue per episode increased year over year primarily due to an increase in Medicare reimbursement rates, the timing of completed episodes, and patient mix under the Patient Driven Groupings Model offset by the resumption of sequestration.

Adjusted EBITDA decreased year over year primarily due to lower revenue and higher cost of services related to labor, fleet, mileage reimbursement, and workers’ compensation costs.

Hospice

The year-over-year decrease in revenue primarily was due to the decrease in average daily census and resumption of sequestration. Admissions increased sequentially from the second quarter of 2022 primarily due to improvements in staffing capacity and an increase in referral sources.

Adjusted EBITDA decreased year over year primarily due to lower revenue and higher cost of services related to labor (including increased use of contract labor), fleet, and mileage reimbursement.

GUIDANCE

The Company updated its full-year 2022 guidance as follows:   

Full-year 2022Revised GuidancePrior Guidance
Net Service Revenuebetween $1,070 and $1,080 millionbetween $1,075 and $1,110 million
Adjusted EBITDAbetween $150 and $155 millionbetween $155 and $170 million
Adjusted EPSbetween $1.37 and $1.50between $1.47 and $1.75

For additional considerations regarding the Company’s 2022 guidance ranges, see the supplemental information posted on the Company’s website at http://investors.ehab.com. See also “Other Information” below for an explanation of why the Company does not provide guidance for comparable GAAP measures for Adjusted EBITDA and Adjusted EPS.

CONFERENCE CALL INFORMATION

The Company will host an investor conference call at 10 AM Eastern Time on Nov. 2, 2022 to discuss its results for the third quarter of 2022. To access the live call by phone, dial toll-free (888) 660-6150 or international (929) 203-0843; the conference ID is 5248158. A simultaneous webcast of the call, along with supplemental information, may be accessed by visiting http://investors.ehab.com. Following the call, a replay will be available at the same location.

ABOUT ENHABIT HOME HEALTH & HOSPICE

Enhabit Home Health & Hospice is a leading national home health and hospice provider working to expand what’s possible for patient care in the home. Enhabit’s team of clinicians supports patients and their families where they are most comfortable, with a nationwide footprint spanning 250 home health locations and 100 hospice locations across 34 states. Enhabit leverages advanced technology and compassionate teams to deliver extraordinary patient care. For more information, visit ehab.com.

OTHER INFORMATION

Note regarding presentation of non-GAAP financial measures

The financial data contained in the press release and supplemental information includes non-GAAP financial measures as defined in Regulation G under the Securities Exchange Act of 1934, including Adjusted EBITDA, leverage ratios, adjusted EPS, and adjusted free cash flow. Reconciliations of these non-GAAP financial measures to the most directly comparable financial measures calculated in accordance with GAAP are presented on the attached schedules.

However, the Company is unable to reconcile, without unreasonable effort, its guidance of Adjusted EBITDA and adjusted EPS to their corresponding GAAP measures due to the inherent difficulty in predicting, with reasonable certainty, the future impact of items that are outside the control of the Company or otherwise non-indicative of its ongoing operating performance. Such items include, but are not limited to, gains or losses related to hedging instruments; loss on early extinguishment of debt; adjustments to its income tax provision (such as valuation allowance adjustments and settlements of income tax claims); and items related to corporate and facility restructurings.  For the same reasons, the Company is unable to address the probable significance of the unavailable information.

Note regarding presentation of same-store comparisons The Company uses “same-store” comparisons to explain the changes in certain performance metrics and line items within its financial statements. Same-store comparisons are calculated based on home health and hospice locations open throughout both the full current period and the immediately prior period presented. These comparisons include the financial results of market consolidation transactions in existing markets, as it is difficult to determine, with precision, the incremental impact of these transactions on the Company’s results of operations.

FORWARD-LOOKING STATEMENTS

Statements contained in this press release which are not historical facts, such as those relating to future events, projections, financial guidance, legislative or regulatory developments, strategy or growth opportunities, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All such estimates, projections, and forward-looking information speak only as of the date hereof, and Enhabit undertakes no duty to publicly update or revise such forward-looking information, whether as a result of new information, future events, or otherwise. Such forward-looking statements are necessarily estimates based upon current information and involve a number of risks and uncertainties. Actual events or results may differ materially from those anticipated in these forward-looking statements as a result of a variety of factors. While it is impossible to identify all such factors, factors which could cause actual events or results to differ materially from those estimated by Enhabit include, but are not limited to, our ability to execute on our strategic plans, regulatory and other developments impacting the markets for our services, changes in reimbursement rates, general economic conditions, our ability to attract and retain key management personnel and healthcare professionals, potential disruptions or breaches of our or our vendors’ information systems, the outcome of litigation, our ability to successfully complete and integrate de novo developments, acquisitions, investments, and joint ventures, and our ability to control costs, particularly labor and employee benefit costs. Our Form 10 Registration Statement dated June 14, 2022 and subsequent quarterly reports on Form 10-Q, each of which can be found on the Company’s website at http://investors.ehab.com and the SEC’s website at www.sec.gov, discuss other risks and factors that could cause actual results to differ materially from those expressed or implied by any forward-looking statement in this press release. We urge you to consider all of the risks, uncertainties and factors identified above or discussed in such reports carefully in evaluating the forward-looking statements in this press release.

Investor Relations Contact


Jennifer Hills 469-860-6061 [email protected]



Media Contact


Erin Volbeda 972-338-5141 [email protected]

Source: Enhabit, Inc.

Enhabit Home Health & Hospice announces participation in upcoming investor meetings

DALLAS – August 23, 2022 Enhabit Home Health & Hospice (NYSE: EHAB), a leading national home health and hospice provider, today announced its participation in the following events:

  • Jefferies Nashville Bus Tour on Aug. 31, 2022
  • 2022 Wells Fargo Healthcare Conference in Boston on Sept. 8, 2022

Enhabit’s President and Chief Executive Officer Barbara Jacobsmeyer and Chief Financial Officer Crissy Carlisle will participate in a fireside chat on Thursday, Sept. 8, 2022 at 4:20 p.m. ET. The presentation will be webcast live and available at https://investors.ehab.com.  

###

About Enhabit Home Health & Hospice  

Enhabit Home Health & Hospice is a leading national home health and hospice provider working to expand what’s possible for patient care in the home. The company’s team of clinicians supports patients and their families where they are most comfortable, with a nationwide footprint spanning 251 home health locations and 100 hospice locations across 34 states. Enhabit leverages advanced technology and compassionate teams to deliver extraordinary patient care. For more information, visit ehab.com.  

Investor relations contact

Jennifer Hills

[email protected]

469-621-6496

Media contact

Erin Volbeda

[email protected]

972-338-5141

Enhabit Home Health & Hospice announces date of 2022 second quarter earnings call

DALLAS, July 7, 2022 /PRNewswire/ — Enhabit Home Health & Hospice (NYSE: EHAB), a leading national home health and hospice provider, today announced it will report its results for the second quarter ended June 30, 2022, after the market closes on Aug. 1, 2022. The Company will host its first investor conference call as an independent, publicly traded company to discuss its results for the quarter at 11 a.m. ET on Aug. 2, 2022.

The conference call may be accessed by dialing 888-660-6150 and giving the conference ID 5248158. International callers may dial 929-203-0843 and give the same conference ID. Please dial in approximately 10 minutes before the start of the call to ensure you are connected.

A live webcast of the conference call and an online replay of the conference call can be found on the Company’s investor website at https://investors.ehab.com. 

About Enhabit Home Health & Hospice 

Enhabit Home Health & Hospice is a leading national home health and hospice provider working to expand what’s possible for patient care in the home. The company’s team of clinicians supports patients and their families where they are most comfortable, with a nationwide footprint spanning 252 home health locations and 99 hospice locations across 34 states. Enhabit leverages advanced technology and compassionate teams to deliver extraordinary patient care. For more information, visit ehab.com.  

Media contact


Erin Volbeda
[email protected]
972-338-5141

Investor relations contact


Jennifer Hills
[email protected]
469-621-6496

Enhabit Home Health & Hospice Completes Spin-off from Encompass Health

Enhabit also announces two new appointments to its board of directors

DALLAS, July 1, 2022 /PRNewswire/ — Enhabit Home Health & Hospice, a leading national home health and hospice provider, today announces it is now an independent, publicly traded company following the completion of its spin-off from Encompass Health Corporation. Enhabit will begin trading regular way on the New York Stock Exchange this morning, July 1, 2022, under the ticker symbol “EHAB.”

“Today marks a new and exciting chapter for our company, and we look forward to embarking on this next phase of growth with our team. We remain rooted in our philosophy of providing a better way to care for patients and their loved ones,” said Enhabit President and CEO Barb Jacobsmeyer. “As an independent company, we will have enhanced strategic and operational flexibility to put the interests of our patients, people, and investors first as we strive to bring high-quality, compassionate care to every patient where they are most comfortable: in their homes.”

Enhabit has more than 20 years of proven expertise, growing into one of the largest providers of home health and hospice services nationally. With over 10,000 employees at 351 locations in 34 states, Enhabit has an award-winning culture that is a key contributor to its continued success. By connecting with compassion, Enhabit’s team members strive to develop strong relationships with patients and their loved ones to help them achieve their individual care goals. 

From 2020 to 2030, the number of individuals in the U.S. over the age of 65 is expected to grow by approximately 30% to 73 million people, creating a greater need for cost-efficient, in-home care options. Enhabit will continue expanding the possibilities of home-based care, driving a low cost of care while achieving superior outcomes for patients.

Upon completion of the distribution, each Encompass Health stockholder as of June 24, 2022, the record date for the distribution, received one share of Enhabit common stock for every two shares of Encompass Health common stock held as of the close of business on the record date.

Citigroup Global Markets Inc. and Goldman Sachs & Co. LLC served as financial advisors and Wachtell, Lipton, Rosen & Katz and Bradley Arant Boult Cummings LLP served as legal advisors to Enhabit in connection with the spin-off.Enhabit announces appointment of two new board members  

In addition, Enhabit is excited to announce an expansion to its board of directors with the appointment of Tina L. Brown-Stevenson and Susan A. La Monica.  

Tina L. Brown-Stevenson – Ms. Brown-Stevenson is a retired executive who brings nearly three decades of experience in the national healthcare payor industry where she developed an expertise in health system analytics and data. Ms. Brown-Stevenson joined UnitedHealth Group in 2008 as the Executive Vice President of Healthcare Innovation and Information Group before being promoted to the Chief Data and Analytics Officer of OptumInsight. In 2012, Ms. Brown-Stevenson rose to the role of Senior Vice President of Health System Analytics and Decision Support, where she oversaw the analysis and management of provider and patient data to validate UnitedHealth Group’s strategy and product offerings, before her retirement in 2019. Prior to joining UnitedHealth Group, Ms. Brown-Stevenson previously held senior leadership positions at several other insurance companies, including Aetna, Cigna, and Partners Healthcare. In addition to her healthcare company experience, Ms. Brown-Stevenson currently serves on the boards of directors of several organizations, including Connecticut Children’s Medical Center and Kyruus Inc., a technology company that provides provider search and scheduling solutions to healthcare organizations. She also serves on the Advisory Board of the Commonwealth Honors College at the University of Massachusetts, Amherst. Ms. Brown-Stevenson has demonstrated her leadership and character through involvement on board roles in community and civic organizations. Ms. Brown-Stevenson also provided patient care for many years as a Registered Nurse before her retirement. As a result of her leadership roles at several large national payors in the rapidly evolving field of healthcare data and analytics and her various private board memberships, Ms. Brown-Stevenson is in a unique position to draw on her extensive experience to advise on opportunities to improve the quality of care for our patients through utilization of strategic technology.

Susan A. La Monica – Ms. La Monica is the Chief Human Resources Officer and Head of Corporate Social Responsibility for Citizens Financial Group, a publicly traded banking and financial services company, where she is responsible for developing human resource strategies to support the company’s business plan and directing its focus on environmental, social, and governance (ESG) issues as co-chair of the Citizens ESG Executive Steering Committee. Additionally, Ms. La Monica played a key role in the separation of Citizens Financial Group from the Royal Bank of Scotland in 2014. Prior to joining Royal Bank of Scotland in 2011, Ms. La Monica held several senior human resources leadership roles at JP Morgan Chase. In addition to her human resources experience, Ms. La Monica has demonstrated her leadership and character through over a decade of involvement on board roles in numerous community and civic organizations. As a result of her diverse leadership roles, Ms. La Monica is well positioned to address a full range of human capital issues, including compensation and benefits, talent acquisition and development, organizational development, and ESG matters.About Enhabit Home Health & Hospice 

Enhabit Home Health & Hospice is a leading national home health and hospice provider working to expand what’s possible for patient care in the home. The company’s team of clinicians supports patients and their families where they are most comfortable, with a nationwide footprint spanning 252 home health locations and 99 hospice locations across 34 states. Enhabit leverages advanced technology and compassionate teams to deliver extraordinary patient care. For more information, visit ehab.com.Forward-looking statements

Statements contained in this press release which are not historical facts, such as those relating to the timing and effects of the spin-off and rebranding of the home health and hospice business, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All such estimates, projections, and forward-looking information speak only as of the date hereof, and Enhabit undertakes no duty to publicly update or revise such forward-looking information, whether as a result of new information, future events, or otherwise. Such forward-looking statements are necessarily estimates based upon current information and involve a number of risks and uncertainties. Actual events or results may differ materially from those anticipated in these forward-looking statements as a result of a variety of factors. While it is impossible to identify all such factors, factors which could cause actual events or results to differ materially from those estimated by Enhabit include, but are not limited to, our ability to execute on our strategic plans, regulatory and other developments impacting the markets for our services, general economic conditions, and other factors which may be identified from time to time in Enhabit’s SEC filings and other public announcements, including Enhabit’s Form 10 Registration Statement filed on May 25, 2022, as amended on June 9, 2022, and June 14, 2022.

Media contact 


Erin Volbeda 
[email protected] 
972-338-5141

Investor relations contact 


Jennifer Hills 
[email protected] 
469-621-6496

SOURCE Enhabit Home Health & Hospice